Developing a new drug used to take 10 years and $2 billion. Machine Learning has cut that timeline in half by simulating molecular interactions virtually.

Generative Biology

AI models design novel proteins and molecules that have never existed in nature but perfectly target disease receptors.

Impact Areas

  • Covid-26 Variants: Rapid vaccine formulation.
  • Rare Diseases: Feasible treatments for small patient populations.
  • Clinical Trials: optimizing patient selection using data.
"Biology is becoming an information technology. We are programming cells." – Modern Biotech